SCHEMBL3706568

SCHEMBL3706568

COC(=O)c1cnn2cc(-c3c(F)cccc3F)c(Cl)nc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 5/20 0.50
AKT2 P31751 5/20 0.50
ALDH1A1 P00352 4/20 0.39
HPGD P15428 4/20 0.39
HSD17B10 Q99714 4/20 0.39
KDM4E B2RXH2 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPK1 P28482 1/20 0.39
MAPK14 Q16539 1/20 0.38
TGFBR1 P36897 1/20 0.37
CASP1 P29466 2/20 0.37
TSHR P16473 1/20 0.37
KMT2A Q03164 4/20 0.37
LMNA P02545 1/20 0.36
HTR2C P28335 1/20 0.35
MEN1 O00255 1/20 0.35
ESR1 P03372 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3804796 0.87 TGFBR1 (0.41) AKT1AKT2ALDH1A1HPGDHSD17B10
SCHEMBL3709331 0.82 AKT1 (0.50) AKT1AKT2ALDH1A1HPGDHSD17B10
SCHEMBL3704097 0.79 AKT1 (0.54) AKT1AKT2ALDH1A1HPGDHSD17B10
SCHEMBL3713237 0.78 KDM4E (0.48) AKT1AKT2ALDH1A1HPGDHSD17B10
SCHEMBL4507101 0.76 KDM4E (0.46) ALDH1A1HPGDHSD17B10KDM4EL3MBTL1
SCHEMBL13606405 0.75 KDM4E (0.46) AKT1AKT2ALDH1A1HPGDHSD17B10
SCHEMBL24501579 0.71 POLQ (0.42) KDM4ELMNAPOLB
SCHEMBL29694746 0.71 POLQ (0.42) KDM4ELMNAPOLB
SCHEMBL4512702 0.70 KDM4E (0.43) ALDH1A1HPGDHSD17B10KDM4EL3MBTL1
SCHEMBL22105272 0.70 TGFBR1 (0.48) ALDH1A1HPGDHSD17B10KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396330-A1 FUSED PYRIMIDINES Bayer Pharma Aktiengesellschaft (DE) 2011-12-21 EP disclosed
WO-2010091808-A1 FUSED PYRIMIDINES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-08-19 WO disclosed